Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.2 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |